China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of Recombinant Human Brain Natriuretic Peptide on Myocardial Matrix Degradation, Endothelial Glycocalyx Injury, and Endogenous Protective Mechanisms in Patients with Acute Heart Failure: A Study Based on TIMP-3, Syndecan-4, and PIII-NP'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136741

Registration Time: 2026/11/15

Type: Observational study

Primary Sponsor: Zhujiang Hospital of Southern Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353276

Published by HT Digital Content Services with permission from Health Daily Dig...